Since the legalization of cannabis in many locales, action in the industry has been fairly heavy, almost too heavy to keep total track of.
LasVegas-based Digipath Inc. (OTC:DIGP) gave its contribution to the cause by announcing the launch of its GroSciences subsidiary. It’s all aimed at fostering product development and bolstering quality for companies among intending to take part in the cannabis marketplace.
Since its inception, according to Tuesday’s news release, "Digipath has collected data on every cannabis sample it has tested. The result is a dynamic, expanding and well-defined understanding of the science of cannabis and its practical application in all phases of product development."
On the launch of GroSciences, CEO Todd Denkin said, “Inventors and product strategists are creating cannabis-inspired product offerings in personal care, cosmetics, OTC and the horticultural market using this amazing plant.
"Unfortunately, many of these great ideas lack the fundamental understanding and science to deliver formulations that can sustain itself in an increasingly competitive market." Hence, he concludes, platforms such as GroSciences are there to facilitate.
Shares in Digipath did, well, grow, Tuesday afternoon by 1.5 cents, or 6%, to 26.5 cents, on volume of 203,000 shares.
